Tumoral PD-L1 expression was independent favorable predictor in ESCC patients with Stage I-II disease or without lymph node metastasis, not in stage III-IV or lymph node metastasis. Here, CD274 is linked to metastatic malignant neoplasm in the lymph nodes.